Estudo de coorte | Uso de contraceptivo oral e risco de câncer ovariano para portadoras de mutações nos genes BRCA1/2.
20 Ago, 2021 | 12:02h
Comentário no Twitter
For #BRCA1 mutation carriers, longer duration of oral contraceptive use (>10 yr) is associated with a greater reduction in #OvarianCancer risk, and the protection is long term. https://t.co/HrrutgaYKX
— Anna Chichura, MD (@AnnaChichuraMD) July 3, 2021